Loading...
Please wait, while we are loading the content...
Similar Documents
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
| Content Provider | MDPI |
|---|---|
| Author | Parisi, Saverio Giuseppe Mengoli, Carlo Basso, Monica Vicenti, Ilaria Gatti, Francesca Scaggiante, Renzo Fiaschi, Lia Giammarino, Federica Iannetta, Marco Malagnino, Vincenzo Zago, Daniela Dragoni, Filippo Zazzi, Maurizio |
| Copyright Year | 2022 |
| Description | We report the time course of neutralizing antibody (NtAb) response, as measured by authentic virus neutralization, in healthcare workers (HCWs) with a mild or asymptomatic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection diagnosed at the onset of the pandemic, with no reinfection throughout and after a three-dose schedule of the BNT162b2 mRNA vaccine with an overall follow-up of almost two years since infection. Forty-eight HCWs (median age 47 years, all immunocompetent) were evaluated: 29 (60.4%) were asymptomatic. NtAb serum was titrated at eight subsequent time points: T1 and T2 were after natural infection, T3 on the day of the first vaccine dose, T4 on the day of the second dose, T5, T6, and T7 were between the second and third dose, and T8 followed the third dose by a median of 34 days. NtAb titers at all postvaccination time points (T4 to T8) were significantly higher than all those at prevaccination time points (T1 to T3). The highest NtAb increase was following the first vaccine dose while subsequent doses did not further boost NtAb titers. However, the third vaccine dose appeared to revive waning immunity. NtAb levels were positively correlated at most time points suggesting an important role for immunogenetics. |
| Starting Page | 1237 |
| e-ISSN | 2076393X |
| DOI | 10.3390/vaccines10081237 |
| Journal | Vaccines |
| Issue Number | 8 |
| Volume Number | 10 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-08-02 |
| Access Restriction | Open |
| Subject Keyword | Vaccines Infectious Diseases Covid-19 Long-term Follow-up Third Vaccine Dose Bnt162b2 Mrna Vaccine Authentic Virus Neutralization Healthcare Workers Mild Or Asymptomatic Sars-cov-2 Infection No Reinfection |
| Content Type | Text |
| Resource Type | Article |
